Xilio Therapeutics, Inc. · NASDAQ:XLO

Xilio Therapeutics, Inc. shareholders

As of Sep 30, 2026, 27 institutions reported holding Xilio Therapeutics, Inc., 44.3% of its shares. Largest: Bain Capital Life Sciences Investors, LLC, Orbimed Advisors LLC and Adage Capital Partners Gp, L.L.C. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Xilio Therapeutics, Inc.ChangeFiled
Bain Capital Life Sciences Investors, LLC664K9.4%no changeNov 16, 2026
Orbimed Advisors LLC592K8.4%no changeNov 16, 2026
Adage Capital Partners Gp, L.L.C.465K6.6%+353KNov 16, 2026
Frazier Life Sciences Management, L.P.423K6.0%no changeNov 16, 2026
Vanguard230K3.3%+28,622Nov 13, 2026
Stonepine Capital Management, LLC189K2.7%−36,902Nov 13, 2026
Sio Capital Management, LLC152K2.2%no changeNov 16, 2026
Merck & Co., Inc.106K1.5%no changeNov 13, 2026
Renaissance Technologies63,5530.90%−600Nov 12, 2026
Morgan Stanley53,6740.76%−3,280Nov 13, 2026

Xilio Therapeutics, Inc. insider trades